Manufacturing

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Decreasing vein to vein time saves lives.

CDMO Exothera and biotech company Remedium are joining forces to scale up the manufacturing process for Remedium’s lead gene therapy candidate for treating osteoarthritis.

Takeda plans to build a new facility in Osaka, Japan, for the manufacture of plasma-derived therapies.

Webinar Date/Time: Tue, Apr 25, 2023 11:00 AM EDT

Curia is collaborating with Corning to advance biopharmaceutical continuous-flow development and manufacturing programs.

The services are based on the company’s PurePrep EasyClean (PEC) orthogonal peptide purification technology.

Sartorius BIA Separations and Teknova will collaborate to combine their technologies in an effort to streamline the downstream purification process.

Samsung Biologics plans to invest more than ₩1.9 trillion (US$1.5 billion) in the new Incheon, South Korea, facility, which will hold a manufacturing capacity of 180,000 L.

Adam C. Fisher, PhD, director of Science Staff and Immediate Office/Office of Pharmaceutical Quality at the Center for Drug Evaluation and Research/FDA, discusses point of care and patient manufacturing with Pharmaceutical Technology editor Jill Murphy.

Stevanato Group will support development and production of pre-fillable syringes for use in Recipharm’s soft mist inhalers.

Webinar Date/Time: Tue, Apr 18, 2023 11:00 AM EDT

Sandoz, a Novartis division, is expected to invest at least $400 million to build a new biologics manufacturing facility in Lendava, Slovenia, to support growing demand for biosimilars.

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Manual aseptic operations make quality practices necessary in the manufacturing of compounded drugs.

Catalent is expanding its UpTempo AAV platform to accelerate the development of gene therapies.

Webinar Date/Time: Tuesday, April 4th, 2023 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST

Actylis new 30,000-ft² API manufacturing facility is located in Eugene, Ore.

Webinar Date/Time: Thu, Apr 6, 2023 11:00 AM EDT

The guidance is intended to build on the existing International Council for Harmonisation (ICH) quality guidance.

PAT is crucial to process control and real-time release in continuous manufacturing of solid-dosage drugs.

Shifts in pharmaceutical packaging have spurred tremendous growth in the pre-filled syringe fill/finish industry.

Stockpiling excess inventory is no longer enough to respond to supply chain volatility.

Technological advances will help ease pressure on pharma supply chains, allowing for greater visibility and less uncertainty.

The trends shaping the growth of the biologics outsourcing industry demand attention.